This article describes a 2-year, multihospital study on the effects of psychotherapy for nonchronic schizophrenic patients. The design and methods used to evaluate the relative benefits of exploratory, insightoriented (EIO) psychotherapy and reality-adaptive, supportive (RAS) psychotherapy when both are provided by experienced therapists against the backdrop of good hospital and psychopharmacological management are presented. Similarities and differences between the two therapies and the therapists are outlined. Special attention is given to the problems in implementing research on long-term psychotherapy. Finally, the strengths and limitations of the present study are discussed.
The study described in this report was initiated during a period in which basic attitudes toward mental illness, both its origins and its treatment, were undergoing radical changes within psychiatry. The era of psychodynamic psychiatry, characterized by psychological observation and psychoanalytic theory, was giving way to the era of biological psychiatry, in which pharmacological treatments and empirical methods emerged as cornerstones. This study was designed to bridge these eras: It used empirical methods to examine the effects of psychological treatment. It tested whether pharmacologically treated schizophrenic patients could benefit from intensive insightoriented psychotherapy.
The practice of psychotherapy with schizophrenic patients was given major importance through the optimistic endorsements provided for it by Harry Stack Sullivan and his students. These spokespeople were enormously influential in drawing attention to both the pathogenic and therapeutic possibilities of psychosocial factors in schizophrenic individuals. They challenged the belief that schizophrenia was a largely organic disorder predictive of a downhill course. In its place, they advocated a model for schizophrenia in which the illness was seen as essentially a problem in relating to other people-a problem that could be altered by a corrective relationship with a trained therapeutic person. This humanistic message and hopeful possibility that curative change could be achieved for schizophrenic patients captured the attention of the entire mental health field. The interest in psychotherapy of schizophrenia was far broader than the actual practice-perhaps because it had a persuasive rationale and certainly because it dovetailed with the widely recognized clinical impression that schizophrenic individuals have a palpably human disorder. Moreover, studies of psychotherapy with schizophrenics were valued as a means of extending psychoanalytic theory into preoedipal object relations.
The present study empirically examined the effects that psychotherapy, when expertly delivered over a significant period of time, can have upon the psychological, social, and instrumental functioning of a carefully selected group of schizophrenic patients. It was the latest in a series of comparative studies and, as such, profited from the experience of earlier studies. It offered a more definitive examination than earlier studies by virtue of using more skilled therapists, who provided better defined and more intensive psychotherapy, over longer periods of time, to a more rigorously defined sample, with a broader range of more reliable and blind ratings of outcome.
This report describes the design and methods used in this study and shows how they compare to previous studies in this area. It also reviews issues in implementation, highlighting this study's strengths and limitations while illuminating generalizable problems and advancements that were outgrowths of this project.
Previous Empirical Studies
Many reviews have been written on the empirical studies conducted between 1960 and 1970 which attempted to evaluate the effectiveness of psychotherapy with schizophrenic patients (Feinsilver and Gunderson 1972; Dyrud and Holzman 1973; Schooler 1978; Gunderson 1979; Mosher and Keith 1980; . Table 1 provides a framework for comparing these studies to each other and to the study described herein. Fairweather et al. (1960) conducted the first significant controlled study of the effectiveness of therapy with schizophrenic patients. That study compared the treatment outcomes of four groups of patients, one of which received individual psychotherapy by moderately experienced therapists 3-5 hours per week. While there was some evidence that the group receiving individual psychotherapy did better than the control group receiving minimal treatment, their improvement was not appreciably better than that of patients receiving other forms of active treatment. This study also indicated that the more chronically psychotic group (which might be expected to conform to modern schizophrenic diagnostic standards) was the least likely to profit from individual psychotherapy. Limitations in the size and the diagnostic definition of the samples made generalization from this study difficult. Other problems were the lack of systematic pharmacotherapy and the uncharacterized nature of the psychotherapy.
In the Massachusetts Mental Health Center study (Grinspoon, Ewalt, and Shader 1972) , chronic patients were treated twice weekly by experienced psychotherapists over a 2-year period. Half of these patients received pharmacotherapy in addition to psychotherapy, and half received psychotherapy alone. The group receiving psychotherapy alone did significantly worse than the group that had drugs added and showed no advantages when compared to a similar group of patients who had chosen to remain in a custodial setting. Conclusions about the value of psychotherapy with schizophrenic patients from this study were limited because of the chronirity of the sample and the absence of a randomly assigned comparison group that received similar milieu and pharmacotherapy in the absence of psychotherapy. Finally, the commitment and enthusiasm of the therapists for doing psychotherapy with schizophrenic patients have been questioned.
A third study employed clinical psychologists schooled in Rogerian client-centered psychotherapy . Like the Massachusetts Mental Health Center study, this study also used hospitalized chronic patients and followed the sample for 2 years. Those who received psychotherapy showed only very modest advantages over those who did not after 18 months, i.e., they had less recidivism in the year following discharge. Conclusions from this study were limited by the inexperience of the therapists, the chronicity of the patients, and the failure to control the pharmacotherapy between the groups. Moreover, the authors judged that only a minority of the patients actually ever became engaged in their psychotherapy.
The fourth study, by Karon and his collaborators (Karon and CGrady 1969; Karon and VandenBos 1970 used both experienced and inexperienced therapists to provide direct analytic (a la John Rosen) treatment to a sample of largely black inner city chronic schizophrenic patients. After 1 year and subsequently after 20 months of treatment, this study showed dramatic advantages for the psychotherapy group over a group treated in a maintenance milieu program. However, it was not possible to sort out whether these advantages were due to the psychotherapy, to uncontrolled variation* in medication, or to the radically different hospital programs in which the comparison group was treated. In addition, the small sample size limited generalizability and required that quite varied treatment conditions be lumped together in order to evaluate treatment effects.
The fifth, and easily the best controlled, empirical study in this area was done by . In this study hospitalized nonchronic patients received milieu treatment to which psychotherapy was added for one group, pharmacotherapy for another, and psychotherapy and pharmacotherapy in combination for yet a third comparison group. A fourth group received the milieu treatment plus electroconvulsive 
Context of the Present Study
The impact of these studies within academic psychiatry was clearly to call into question the claims for psychotherapeutic efficacy and to cast doubt upon the wide application of psychotherapy. Moreover, these studies, with their equivocal findings, changed the question from whether it was ethical to withhold psychotherapy from a schizophrenic patient (for whom it might otherwise be available) to a new ethical question-whether it was appropriate to give psychotherapy when its value had not been demonstrated. While most of these studies sought to protect the usefulness of psychotherapy be citing "gifted therapists" and "special patients," few training programs continued to espouse the value of this clinical service.
Despite the decline in enthusiasm within academic psychiatry for the psychotherapy of schizophrenia, these studies had little impact on the practices of those who had been advocating and providing this service. For them, the limitations of the studies precluded any serious judgment about the value of the work as it was practiced. Thoughtful proponents of psychotherapy for schizophrenic patients felt that the studies failed to use therapists who were sufficiently skilled, failed to follow patients for long enough periods of time to find differences, and failed to use samples of patients on whom good results could be expected. Finally, they argued that the nature of the changes caused by psychotherapy-when well conducted on suitable patients-were not likely to be tapped by the outcome measures of recidivism and role performance that typically were used.
The Clinical Research Branch of the National Institute of Mental Health recognized the danger of a premature closure to this ongoing and reasonable controversy. In fact, the divergent results obtained by Karon and his colleagues and by May, as well as the divergent interpretations by empiricists and clinicians, seemed to indicate that these studies had aggravated rather than resolved the controversy. There existed a clear possibility of foreclosing a treatment that might offer the only hope for truly deep and enduring change in schizophrenic psychopathology. This possibility was recognized even by those whose criticisms of psychotherapy's effectiveness had been vindicated by its disappointing performance in these studies. Thus, the ongoing debates about its effectiveness and the obvious importance of the issue made further and more definitive studies highly desirable. As a result, the National Institute of Mental Health, through its Center for Studies of Schizophrenia, encouraged sophisticated and experienced therapists to get involved in framing future research so that the effects of psychotherapy might be more suitably evaluated (Friedman, Gunderson, and Mosher 1973; Gunderson and Mosher 1975) .
It was in this context that the preliminary proposal for the current study was prepared by Alfred Stanton in June of 1972. This was followed by consultations with National Institute of Mental Health staff and meetings with potential collaborators. Of the many institutions approached about possible collaboration, most of those that had the strongest identification and tradition with the practice of intensive psychotherapy still felt they could not randomly withhold this treatment from patients admitted to their institutions. There were, however, a few institutions that had a commitment to intensive psychotherapy, operated within a university/medical school setting, and these institutions were enthusiastic about participating. Among these, were the Illinois State Psychiatric Institute, the New York State Psychiatric Institute, and Boston University. Meetings with representatives from these and other interested institutions ultimately led to the research design that was submitted to the National Institute of Mental Health in 1973. The proposal was for a collaborative project with the above four institutions. Approval was given for a pilot study to be conducted on a time-limited basis at the two Boston centers to test the feasibility of the design. At the conclusion of the pilot phase, a proposal for completing this study was awarded and the project was begun in 1976. In 1978, the Bedford Veterans Administration Hospital was added to increase the sample size.
Design
The intention of this study was to provide a fresh examination of whether intensive psychotherapy added appreciably to the benefits of more usual treatment of schizophrenic patients. To provide a rigorous test of this issue, we compared exploratory, insightoriented psychotherapy (EIO) to a control treatment which consisted of a high quality but more usual form of psychotherapy called realityadaptive, supportive (RAS) therapy. This design was an effort to isolate the more specific effects of the EIO therapy. Practical, ethical, and scientific considerations precluded a comparison of the EIO therapy with a treatment condition in which good quality psychiatric management was not included but which might have more readily demonstrated the nonspecific advantages of the EIO treatment. Both treatments were provided against a backdrop of good hospital and pharmacotherapeutic management.
Our design attended meaningfully to a number of areas subsequently set forth as methodologic standards for treatment outcome research in schizophrenia (Carpenter, Heinrichs, and Hanlon 1981) . We employed varied and reliable outcome measures, prognostic assessments, and diagnostic evaluations. The latter included both clinical and standardized research criteria. Our instruments were varied in their content, intentions, and raters. Built into the study design was an awareness that the effects of the experimental condition (EIO) could not be expected to be seen, let alone measured, until a significant time in treatment had transpired. Our design allowed the participating clinicians to exercise their best clinical judgment about such issues as hospitalization or drug use. Thus, its results could be expected to convey the first meaningful information about unencumbered high quality treatment of schizophrenia.
In the sections that follow, we present the overall design-describing the patients, the therapists, the therapies used, and the assessments that were conducted on each of them. In each instance, the issues encountered in implementing the design and in maintaining it over time are discussed. Some of these problems are familiar to investigators who have attempted to do longitudinal research on schizophrenic samples; others are more familiar to those who have attempted to do controlled outcome research. Still others are familiar to investigators who have assembled large data masses for any purpose. Our intention in describing these problems is to inform readers of the adjustments and solutions that were part of doing this project. It is hoped that other investigators who have similar ambitions to conduct controlled outcome studies of longterm treatment thereby will be informed. It is also hoped that this description will allow readers to understand our study's strengths and limitations, and thereby join in the interpretation of the results that are presented in subsequent reports.
The Patient Sample. The selection of a patient sample was intended to identify a mid-range prognostic group of clearly schizophrenic patients who were neither too chronic to be expected to respond to treatment nor so acute as to improve independently of the given treatment (see table 2 ). In this way we used the sampling goals set forth by . Several departures from May's method of selecting a sample should be noted, however. First we used an opera tionalized standard for ruling out patients who were "too chronic." Inclusion in this study required that patients had functioned outside of a hospital and off medications in some major role for at least 4 consecutive months out of the preceding 2 years. In addition to using two independent clinical diagnoses, we employed the standardized research criteria for the diagnosis of schizophrenia (discriminating criteria for schizophrenia; DCS) that had evolved out of the International Pilot Study for Schizophrenia Bartko 1973, 1976) . This criterion set provided an assurance that the schizophrenic sample was operationally defined in accord with the best international standards then available.
Because of the limited number of suitable patients who had personal and/ or insurance resources to support the EIO treatment for a full 2 years-especially on the Boston University side of the project-patients were eligible to receive financial support from the grant for that fraction of their ' psychotherapy costs (either EIO or RAS) which they would otherwise be unable to afford. As such, participation and continuation in the study was not influenced by the patient's ability to pay. Based on these selection procedures, all admissions to the participating hospitals who received a diagnosis of schizophrenia or possible schizophrenia at time of admission were screened for possible inclusion in the project.
Using previous studies on the psychotherapy of schizophrenia as a guide, Cohen's (1977) power analysis indicated that a sample of 60 patients in each treatment condition would be needed to detect a moderate incremental advantage for the experimental condition at the .05 level of significance. Because we believed that the effects from psychotherapy could not be expected to occur before a minimum of 6 months in treatment, this duration was set as the cutoff for inclusion in the project. Given an estimated 33 percent dropout rate in the first 6 months, we expected that we would need to recruit a total of 180 patients for the study. In addition to the projected sample size (of 120 patients), the study design called for half of the sample to come from McLean Hospital and half from Boston University (including the Veterans Administration hospital).
Patient recruitment. Of the approximately 2,000 psychotic patients whose admission notes were reviewed, 186 were found suitable for entry into the study. Most of the other 1,800 were excluded on the basis of diagnostic impurity, but many were further excluded by virtue of age, being too chronic, already being "in therapy," or possible drug/alcohol abuse. Of the 186 who were suitable, 164 consented to participate and were randomly assigned to treatment. There were no differences in the baseline characteristics between the 164 who consented and the 22 who did not. Baseline characteristics of this entry sample of 164 are shown in table 3. Half of the sample had not had a prior psychiatric hospitalization, and two thirds had had no prior exposure to individual psychotherapy. Thus, patients' psychopathology and subsequent treatment response often were not confounded by prior treatment effects. Scores on the Vaillant and Phillips prognostic indices (see Appendix B for scale references) confirmed that we had included a generally mid-range prognostic group as called for by the design. Also, as planned, half of the sample came from McLean Hospital and half from Boston University.
As table 3 shows, there were dear institutional differences along expected lines. At McLean Hospital, patients were largely white, middleto-upper class, and well-educated. Most were unmarried and still totally dependent on their primary families. The Boston University inpatient service to which most patients were admitted is part of the Solomon Carter Fuller Community Mental Health Center (SCFCMHC). The Mental Health Center served a largely black, inner city, lower class patient population. The Bedford VA Hospital is another Boston University affiliated hospital which is located in the suburbs and serves a regional population of predominantly male veterans, most of whom have a longterm relationship with the hospital. Patients at the VA were more likely to have had prior hospitalizations than those at the other two institutions.
Diagnostic approaches to schizophrenia during the 10-year course of this study changed from DSM-II (American Psychiatric Association 1968) to the narrower and more specified criteria found in DSM-UI (American Psychiatric Association 1980). In 1978, after this trend toward narrower diagnostic criteria became apparent, but before publication of DSM-1II, we conducted a diagnostic study in which our first 48 study patients were blindly rediagnosed using several different sets of diagnostic criteria . We found that 13 (27 percent) of those patients who were considered suitable for the study (i.e., who fulfilled clinical and World Health Organization diagnostic criteria for schizophrenia) were diagnosed as either manic-depressive (4 percent) or schizophreniform (23 percent) by DSM-UI criteria. Yet even these patients were identifiable as schizophrenic by at least one other modern criteria set (Feighner et al. 1972; Taylor and Abrams 1975) .
Sample maintenance. More formidable problems than the diagnostic purity and size of the sample at entry were presented by the problem of dropouts, i.e., sample attrition. Of the 164 patients who entered the study, 69 (42 percent) dropped out before qualifying as study patients, i.e., before completing the minimum 6 months in their assigned treatment modality. Attrition in the sample of study patients continued during the project (as shown in figure 1) at either Boston University or the VA. In the latter settings the standard treatment emphasized rapid discharge and more exclusive reliance on pharmacotherapy both during hospitalization and after discharge. We also inferred that the patients at the latter institutions were less accus- Frank et al., in preparation; Gunderson, in press ). Summary. The diagnostic procedures used in this study appear to have succeeded in identifying a broad middle range of psychopathology within the study sample while eliminating those psychotic patients who were clearly reactive, primarily affective, or very chronic. Thus, our sample included the vast majority of schizophrenic patients for whom the possibility of psychotherapy could reasonably be under consideration. On the other hand, our plan to achieve a sample size of 120 patients was frustrated by the fact that maintaining our sample in their assigned treatments over the 2-year period was considerably more difficult than we had anticipated. Compounding the problem of sample attrition was the additional concern that patients who remained in treatment for long periods might not be representative of a broader schizophrenic population. In this regard, we were partially reassured by the fact that in most major baseline comparisons no systematic differences were found between patients who dropped out and our study sample of patients who remained in treatment beyond 6 months.
Although it was an unfortunate occurrence, the dropout problem itself has provided the opportunity to study the determinants of engagement and continuance in the psychotherapy of schizophrenic patients.
The Therapist Sample. A variety of assessments were done to evaluate whether the RAS and EIO therapists differed in the ways that were called for by the study's design. We found that
McLean therapists, as a group, were more experienced than therapists at either BU or the VA. Moreover, in their attitudes, beliefs, and practices, the EIO and RAS therapists at McLean were more distinct than was the case at the other two hospitals. Overall, however, table 6 shows that EIO therapists believed in the importance of developmental factors in treatment and etiology, in the alterability of the core psychopathology of schizophrenia, and in a nondirective technique that relied heavily upon evolution and change in a transference relationship. In contrast, the RAS therapists placed more importance on hereditary factors in the etiology of schizophrenia and believed that these factors led to unmodifiable aspects of the schizophrenic patient's psycho- pathology. They also believed in a directive treatment approach that involved the formation of a supportive relationship. Other comparisons (table 7) suggested that RAS therapists were more active, more likely to see problems as external, and less gentle and restrained than their EIO counterparts. A more extensive description of the differences between the EIO and RAS therapists at the three hospitals can be found elsewhere .
Therapist maintenance. Unanticipated and previously unreported issues were encountered that may be intrinsic to conducting a long-term project using experienced therapists (Frosch and Gunderson 1982) . One of these involved our ongoing efforts to keep the therapists blind to the study's hypotheses and specific outcome variables. These efforts were intended to preclude the possibility that therapist expectancies might bias their communications to patients and either their own or their patients' reports to us. Another problem was the erosion in therapists' morale and the resultant decline in the quality of their recordkeeping over time-perhaps understandable given our demands for repetitive ratings by clinicians. Yet another roadblock was the very practical problem that busy senior therapists often did not have therapy time available when new patients joined the study. The unpredictable availability of therapists for new patients meant that therapists took an uneven number of cases. The maximum number for any EIO therapist was three, but for RAS therapists the number was much larger. (One therapist had 11 patients, and three others had more than four.) Thus the influence of some therapists is overly represented in the results. A final arena in which problems surfaced involved the concern by some RAS therapists that the investigators hoped to demonstrate that their treatment practices were second rate. Perhaps because of this suspicion, they were less willing to tape record sessions and to undergo personal evaluations. Only 11 of 27 RAS therapists (41 percent) taped sessions compared to 38 of 54 EIO therapists (70 percent), and eight RAS (30 percent) compared to 20 EIO (37 percent) therapists completed a self-administered thematic apperception test (TAT).
Summary. Selection of therapists was generally consistent with the study design. On the whole, therapists were experienced in treating psychotic patients and were committed to an ideologic approach consistent with the type of therapy that they were expected to practice. Nevertheless, there remained considerable variability in amount of experience (from 5 to 35 years) that the therapists had. Moreover, at BU, the differences between RAS and EIO therapists were less marked than the study design required. Special problems in the morale of participating therapists were identified.
The Therapies. Other than the specific requirements of the EIO and RAS therapies, the program of treatment for patients in this research was to be similar to that already in use at the various hospitals. In this regard, all three hospitals had a general approach to treatment that used similar medications, group activities, and consultations with families and others of concern to the patient. However, as has been noted already, there were some obvious differences among the hospitals in the length of stay and the degree to which senior staff were expected to play an active role in the treatment of inpatients.
The patients in both EIO and RAS groups were managed on the same wards by the same staff. To minimize the potentially confounding effects of hospital differences on our EIO-RAS comparisons, equal numbers of RAS and EIO patients were to be treated at each setting. Participation in ward group activities, meetings, recreational, occupational, or educational activities, for example, were in accordance with the usual hospital practices. However, specifically designed therapeutic group activities such as group psychotherapy, family therapy, and couples therapy were restricted to not more than 3 months' duration and the total number of sessions was never to exceed 3 hours a week. This constraint was proposed to minimize the potentially confounding effects of exposing subjects to additional uncontrolled and possibly powerful treatment modalities.
Except for the fact that study patients were expected to continue in their assigned form of psychotherapy for as long as it was deemed clinically advisable, the study imposed no proscriptions or directions for the aftercare of patients as they left the three participating hospitals. Thus, discharged patients went to the usual range of destinations including homes, halfway houses, rehabilitation programs, or solitary apartments.
All study patients were placed on antipsychotic medications chosen by the managing inpatient psychiatrist. It was expected that drugs would ordinarily be continued for a considerable length of time, probably well into the posthospitalization phase of treatment. To assure an overall high level of drug management and consistency in the prescribing behaviors for both study groups, any plan to change or discontinue prescription of antipsychotic medications was given an external, independent review by a senior consultant (Dr. Jonathan Cole).
Therapy randomization. All patients found appropriate for inclusion in the study were randomly assigned to either the expressive insight-oriented (EIO) treatment or the reality-adaptive, supportive (RAS) treatment. Although judgments were made by the research psychiatrists of each patient's presumed suitability for one or the other form of psychotherapy, this opinion was neither transmitted to the clinical team nor allowed to bias the randomization procedure. Nor was a patient's financial status given consideration in this process. Assignment to EIO or RAS was achieved by a random numbering system within an unrelated office.
In an effort to keep the two treatment groups balanced in both size and critical baseline characteristics, periodic checks were made of patients' scores on selected baseline variables (e.g., on the Vaillant and Phillips prognostic measures), and patient recruitment (e.g., number of consents given and withdrawn) was monitored throughout the project. On those occasions where imbalances appeared, a weighting was introduced into the randomization procedure to reestablish comparability of the EIO and RAS groups at baseline.
Reality-Adaptive Supportive Psychotherapy (RAS). The name given to this therapy reflects what were expected to be its major components. It roughly conforms to the idea of psychotherapeutic management introduced by May (1968). As called for in the present study, RAS therapy was intended to be a very high quality version of what has become perhaps the most widely practiced form of therapeutic care for schizophrenic patients. It is a form of therapy whose advantages over no treatment have been convincingly demonstrated in previous research (Hogarty et al. 1973 (Hogarty et al. , 1974a (Hogarty et al. , 1974b . By attempting to provide this form of treatment in a high quality, expert way, the study design focused on what, if any, were the specific advantages that could be accrued from the more intensive EIO treatment.
RAS was to be given up to-but not more than-once weekly with an expectation that the frequency of visits would taper into an "as needed" scheduling with the passage of time and the movement into outpatient settings. While no absolute proscription on meeting for more than one 50-minute hour (or twice for Vi-hour sessions) each week was made, there was an expectation that the RAS approach would represent a nonintensive form of psychotherapy conducted according to the usual and best clinical judgments of those who advocated it for schizophrenic patients.
Description (see table 8 ). The description and examples which follow for RAS therapy-and later for EIO-are paradigmatic; they emphasize the distinctive features of the therapy as planned and obviously do not reflect how the therapies were always conducted.
The RAS therapist saw the prescription and maintenance of a good drug treatment regimen as the cornerstone of treatment for these patients. This viewpoint does not mean that the psychotherapy itself focused on discussing drug administration and side effects. In fact, the psychotherapy generally focused on problems in the current living situation of the patient. In contrast to the EIO therapy, there was little attempt to explore the past and to seek correlates between past experience and the present. Rather, the exploration of the present was intended to identify problems that could be solved or that could be expected to recur in the future so that more effective coping strategies could be mapped out.
Another major feature of the RAS therapy was its focus on the patient's behavior itself rather than the potential covert meanings behind that behavior. RAS therapists felt comfortable in the role of experts who could encourage the use of certain behaviors and attempt to prohibit other behaviors that were seen as maladaptive. In this role, the therapist was frequently very active in the selection of topics to be discussed and in giving patients advice and direction. They also A third major aspect of the RAS treatment was its reality-supporting aspects. Distortions were actively identified as symptomatic of the patient's illness and therefore as something to be suppressed and extinguished if possible. Therapists would frequently be self-revealing in order to clarify reality if they saw it being misjudged by their patients. RAS therapists did not see the patient's relationship to the therapist as a model by which to understand the patient's problems in relating to the world more generally. It was commonly accepted that patients could learn from the therapist's example and might, over the course of time, identify with the therapist's active problem-solving approach.
Examples. In the first example, a patient reports to his therapist that he had attended a party but had left early and had gone home because he was upset. The RAS therapist attempts to identify the consequences of this behavior. "If you leave such parties, you will not be able to make friends, and this will only add to your sense of loneliness." He helps the patient anticipate future situations in which such reactions might recur. "The next time you go to a party, we should discuss this because you can expect to feel similarly upset." He feels free to suggest that the patient's reasons for being upset are unrealistic and that the fearful consequences he expected from staying are symptoms of his illness. As a result, the RAS therapist might then direct the patient not to act on this feeling, but to stay at the next party with the added encouragement that he believes the patient is able to do this and will be better off if he does.
In a second example, a patient reports that his mother is badgering him to get out of the house and get a job. Here, the RAS therapist points out that getting out of the house might have some advantages, given the unpleasantness that he experiences within it-again focusing on the consequences of the behavior and implying some potentially adaptive alternative. The therapist might also inquire if the patient would like him to speak to his mother. If so, he might do so and, in the process, might attempt to educate the mother about the disabilities associated with her son's illness and advise her that her chiding is counter-productive. He might explore the possibilities and then encourage the patient to spend time outside the house. He might point toward structured activity programs or sheltered work programs, perhaps in the hope that the patient could change. Such advice could also be given as a preventive measure against the symptomatic relapse expected from continued exposure to parental stress. The therapist would probably explore whether becoming upset resulted in symptoms and whether an increase in medications could help to reduce the stress associated with the experience.
Expressive Insight-Oriented Psychotherapy (EIO). The EIO condition was intended to represent the most commonly practiced type of intensive psychotherapy used with psychotic patients. It was, in effect, a form of analytic psychotherapy adapted from that described by Frieda Fromm-Reichmann (1950) and having some parallels with the type of analytic therapy provided in the Massachusetts Mental Health Center study (Grinspoon, Ewalt, and Shader 1972). Although linked to psychoanalytic theories of therapy and psychopathology, it was by no means psychoanalysis. Rather it was an amalgam of principles and practice derived from the considerable traditions of exploratory therapy in Boston, Washington, and other major teaching centers. It should be noted that both the EIO and RAS therapies described should be understood as "ideal" rather than prescribed modalities.
The EIO approach supports and utilizes the schizophrenic patient's available ego functions; it does not attempt to interpret primary process productions of psychotic patients in the manner of John Rosen (1953) nor does it encourage the development of regressive transferences as has been described by Searles (1965) . While EIO therapy incorporates many of the supportive features found in the RAS condition, these features provide the backdrop for a markedly different goal. The purpose is the detailed exploration of the patient's inner experience and relations with others. Its aim is to increase insight, i.e., understanding aspects of mental activity which contribute to illness and its continuation with the expectation that such an exploration will be of benefit to the patient insofar as it succeeds in increasing his selfunderstanding.
EIO therapy is intended to be conducted three or more times per week. It is expected that the development of a sufficiently close relationship with schizophrenic patients requires much time and availability, and that such a relationship is a prerequisite to a meaningful examination of the schizophrenic patient's problems. The increased frequency of visits also reflects the idea that exploration of the relationship in itself requires that both patient and therapist be immersed in it. In this way, the distinctive features of the patient's relatedness to others may become apparent and subject to exploration.
Description (see table 8 ). The following characteristics of EIO discriminate it from RAS and from other forms of psychotherapy (see also Stanton, in press).
The patient is brought to understand the purpose and the general nature of the therapy as soon and as fully as his condition permits. He is encouraged to understand and to question when necessary.
The broad aim of developing insight is the mechanism that is assumed by the participants to be an agent of improvement (Stanton 1978) . EIO therapy is not necessarily directed at the recovery of forgotten experiences, the learning of a theory of psychodynamics applied to the patient, or the discovery of undesirable patterns of interpersonal behavior, how they came about, and their unfortunate implications. It may, however, include any or all of these. It is a general assumption that each patient will have some difficulties in accepting new information about himself. An appropriate aspect of the therapy is the clarification of the nature of these difficulties, as a means of diminishing them.
Information about the patient's conception of the therapist and the patient's feelings about the therapist is used both as a barrier to progressive learning in the treatment situation, and as a pathway to uncover aspects of experience of which the patient is either unaware or not clearly aware. Although the therapist is conscious of transference meanings, transference interpretations are used sparingly, especially in the early phases of therapy. Analogously, therapists vary in the degree to which they may wittingly use their own responses to the patient as sources of further information, or.
in some cases, speak of their own responses as a contribution to the patient's efforts.
Therapists often make use of information about unusual states of consciousness-the symbolic content of delusions, hallucinations, or dreams. They communicate their understanding of the meanings of these disguised symbolic products of the patient's mind to aid in the understanding of wishes and tendencies of which the patient may not be aware. Some therapists use these materials freely, others sparingly, but all use them to some extent, and relatively systematically, in their pursuit of greater understanding of the patient.
The patient is assigned an active role in this process, a role that is assumed at a rate which is thought to correlate with his improvement. Insight is to be sought by the patient, and the understanding that he achieves is of much value; the therapist's understanding is nothing but a vehicle through which the patient may be helped. The patient is not given insight or intrapsychic understanding, but he must strive for this understanding to achieve it. He must reach an understanding of the fact of his illness, its nature, and its implications; such insight goes far beyond the "insight into illness" concept that is limited to recognition that one has a disability.
The intrinsic nature of intensive psychotherapy is almost entirely communicative; communication is substantially all that either the therapist or the patient attempts within the session. It is largely verbal, with the implications of the clarity and complexity that verbal communication can contain, but it does involve nonverbal gestures-for example, tones of voice, gestures, postures, and manner-inasmuch as they are communicative. Further, the contents are not only communicative; they are consciously and intentionally communicative, as a subordinate goal toward the development of self-understanding in the patient.
EIO clearly differs from psychoanalysis in that there is no explicit use of the basic rule of free association as a conscious tool. Also, while initiative is given to the patient in selecting topics with which to begin the session, this practice is breached frequently. The therapist often introduces topics at variance with those of the patient or actively inquires about the patient's concerns. Another difference is the lack of allegiance given to such concepts as the complete analysis of a transference psychosis. Finally, consistent with the widely accepted view that material from unconscious fantasies frequently is intrusive and disorganizing in schizophrenia, the target area for the development of insight is different in EIO than in classical psychoanalysis. The ego functions that are emphasized to develop insight include the following: strengthening of the patient's capacity of self-observation; enlarging his grasp of context and his recognition of its relevance; encouraging deliberation and thoughtfulness through experience of their value; and educating the patient to develop a more sophisticated system of moral judgments to replace or modify a primitive feeling of guilt.
Examples. For the patient who has reported leaving a party early, the EIO therapist might inquire in more detail about what was going on at the party. The therapist's intent would be to isolate the precipitant and focus on the interpersonal context in which the maladaptive behavior began. Secondly, the EIO therapist might try to understand more about the nature of the patient's being upset: had the patient felt that way before? when? where? In this way, an attempt might be made to anchor the experience within the patient's body (thereby helping to establish ownership and identity) and also to anchor it in the patient's ongoing life experience so that some perspective on this feeling state and the patient's flight from it can be attained. Finally, the nature of the feared consequences might be explored, i.e., the fantasies that mobilized the retreat from the party: "What do you imagine would have happened?"
In the second example in which the patient complains about conflict with his mother, an EIO therapist might want to know what it is that made conflict with, or anger from, the mother so upsetting to the patient. A search for the internal meaning of the precipitating circumstance might then begin, with the focus not on the event, but on the reactions to it. This process might be followed up by an exploration of the patient's feeling unable to stand up to his mother or by an examination of his refusal to do things his mother asks out of spite. Here, again, exploration of the patient's fantasies of what would happen if he fought back would be likely. Although the questions might not be much different from those which a RAS therapist would ask, the intention would be to use the patient's answers as a means to explore the patient's inner life. Finally, the therapist would be aware of, and potentially would explore the transference meaning of, this problem, e.g., "Had you hoped I might do something to help you with your mother?" On a deeper level, the therapist might be concerned that this incident was brought into the therapy because it mirrored an experience of being badgered within the therapy itself. Table 9 contains the results of a number of preliminary comparisons done to determine whether the EIO and RAS groups differed in important aspects of treatment that might be expected to affect treatment course or outcome but were not randomly assigned or controlled. As shown in table 9 and in accord with the study design, there were no significant differences between the groups with respect to amount of antipsychotic medication prescribed, amount of ancillary treatment provided, and use of alternative residential programs in either the first or the second year of the study. Although there was a trend for EIO patients to receive more family therapy than RAS patients, this difference proved to be due to a few outliers (three McLean EIO patients) who received the maximum allowable amount of family treatment. When they were removed from this set of comparisons, the observed difference disappeared. The only significant differences that emerged, which could not be attributed to the influence of outliers, were in the number of days the patients spent in the hospital in the first year and on lithium in the second year. The finding that RAS patients received more lithium than EIO patients is consistent with the impression that, as a group, the RAS therapists were more likely to see affective symptoms in their patients and probably were more aggressive It is a subject that we will address in future reports. The finding that the EIO group initially spent more time in the hospital than the RAS group likewise is open to a number of interpretations and requires careful examination. Since, however, it is a finding that bears on the main hypotheses tested in this study, it is discussed in the presentation of our outcome results which follows . The next set of questions of implementation concern whether patients who were assigned to either the RAS or EIO condition received the psychotherapy called for by the design. In table 8 we outlined seven areas in which differences between the EIO and RAS treatments might be expected to occur. Although this outline focuses on differences, areas of overlap are also cited.
Implementation
With respect to the first area, objectives, the earlier reported data on the therapists' attitudes indicated that they subscribed to quite different objectives consistent with the definitions in table 8. Evaluation of whether the therapies differed in the other six areas were done using process measures obtained from tapes, from therapists' reports (Stone scales, see Appendix B), and from patients' reports (selected BarrettLennard items, see Appendix B). The results of these evaluations are contained in table 10. Insofar as the expected similarities and differences were validly tested by these process measures, the results indicate that the treatments generally conformed to the study design. The RAS and EIO therapies differed from each other as expected in the areas of interview focus, psychic arena, transference, and, to a lesser extent, temporal focus. In the area of countertransference, our results were mixed, but the measures of this construct fell short of what we would consider optimal validity. In the area of techniques, it was reasonably clear that the expected differences between the EIO and RAS treatments were not found. In fact, it appeared from these data and from clinical impressions that the EIO therapy contained major supportive elements despite the relative deemphasis of these in the theory of therapeutic change described in this treatment and ascribed to by the therapists. This finding is similar to Wallerstein's (1983) recent observations regarding the Menninger Psychotherapy Project. Table 10 shows that the EIO and RAS conditions differed markedly in the frequency of sessions held. The EIO group received somewhat fewer sessions than planned. Nevertheless, the approximately two sessions per week given to EIO patients were still far more than what RAS patients received. Moreover, this figure actually is an underestimate due to the inclusion in the calculations of therapist absences. When, for example, therapist vacations and holidays were taken into consideration, the frequency of sessions for both EIO (2.41 sessions/week, n = 42) and RAS (0.71 sessions/week, n -51) groups rose to the planned levels in the first year, and to nearly those levels (EIO: 2.16 sessions/week, n = 32; RAS: 0.61 sessions/week, n => 33) in the second year. Although the RAS group did not taper as dramatically as expected in the second year, the ratio of EIO:RAS visits was consistently more than 2:1, and this was true at all three institutions.
Summary. This study set out to evaluate whether a more intensively provided insight-oriented therapy would show advantages over the reality-adaptive, supportive therapy more commonly used in the treatment of schizophrenic patients. Both forms of individual psychotherapy were to be provided on a controlled basis and to differ in frequency, content, and intention but to share a common backdrop of good hospital treatment.
The question of whether the study provided therapies that conformed to the design requires a complicated answer. With the exception of a greater amount of lithium received by RAS patients in the second year, and a greater amount of hospital treatment received by EIO patients in the first year, the treatment programs of the EIO and RAS patients did not significantly differ; and the two groups received comparable amounts and types of ancillary therapy.
In the form and content of the psychotherapies provided, the EIO and RAS treatments differed in ways that were consistent with the study's design. That is, there were clear differences between the EIO and RAS therapies in their objectives, areas of focus, amount of attention to the past, concern for unconscious motivations, and efforts to explore transference. The therapies had in common their employment of supportive techniques. Although it appears that we were indeed comparing the effects of two qualitatively different types of psychotherapy, in some areas, the differences between the therapies may have been more a matter of degree than kind (i.e., more quantitative than qualitative). However, additional data would be required to conclude that these and possibly other components of the therapies existed as continuous variables with greater intersession and intertherapist differences than intermodality differences.
The Assessments
To serve as a background for the section which follows, table 11 provides a summary of (1) the measures, (2) the source of data (the rater, and to whom administered), and (3) scheduling. In addition, Appendix B gives descriptions for each of the measures, separated by type (antecedent, process, and outcome).
Outcome Measures. The selection of measures for this project was made with several important considerations in mind. We wanted to measure outcome of psychotherapy along a number of dimensions, using measures that had shown promise in previous studies of schizophrenia (e.g., the Visual-Verbal Test, a test of thought disorder used by Karon) and also a host of other measures that would capture conceptually the areas of growth and change felt to be important by therapists treating schizophrenic patients. Another goal was to pay special attention not only to the outward behavioral signs of change (e.g., role functioning, signs, and symptoms) that would be of interest regardless of the clinician's theoretical orientation, but also to the kinds of intrapsychic change assumed to be more specific to the dynamically oriented therapy that was of particular interest in this project (e.g., integration of one's illness, other cognitive changes, and changes in ego functioning; see Gunderson and Gomes-Schwartz 1980) . In addition to covering a broad array of outcome domains, an effort was made to gather data from a variety of sources, including patients, therapists, significant others, ward staff, blind evaluators, and project staff, each of whom would have somewhat differing views and perspectives on the patient's course and progress. Clearly, we knew that the therapists who provided data about their own patients would be neither blind nor uninvested in the results. Yet we believed they would provide a unique window on the relationship between themselves and their patients, as well as an inside perspective on the course of treatment and the patient's progress. Similarly, we knew that significant others, ward staff, and project staff also would not be blind to the patient's experimental condition. Again, however, we expected that they would provide unique perspectives on the patient. In contrast, we knew that the independent, blind evaluators, who would be informed of neither the patient's experimental condition nor the specific hypotheses being tested, and who would not be invested in the study results, would know less about the patient but would be in a position to provide a more neutral or objective view.
Finally, attention was given to obtaining outcome measures repeatedly and at regular intervals so that variations in the nature of change occurring in the EIO and RAS conditions over time could be examined. The time periods selected for each measure took into consideration the ease and cost of obtaining the data (including the burden to the patient and/or therapist). Such factors were weighed against the relative contribution of frequent assessments of a particular outcome area.
Process Measures. Similar considerations governed our selection and timing of process measures. We needed measures that would tap the ongoing process of psychotherapy and that would be generalizable across many kinds of therapies, as well as measures that would help to clarify the particular characteristics intrinsic to successful EIO and RAS therapy. For the former, we were interested in such things as amount (quantity and frequency) of the treatments under study (EIO and RAS), other adjunctive treatments (medications, other therapies, hall activities), and milieu characteristics (e.g., the ward atmosphere). The search to understand the characteristics specific to successful EIO and RAS treatment led to the tape recording of therapy sessions, from which a number of measures of therapists' behavior were abstracted. In addition, paper and pencil tests and interview data from both patients and therapists were used to examine specific therapeutic techniques (e.g., interpretation, clarification) as well as patients' and therapists' perceptions of one another.
Antecedent Measures. The final group of measures important to our study were those tapping antecedent characteristics of patients and therapists that might be expected to affect process and outcome directly, as well as to affect outcome indirectly through their mediating effects on process.
For the patient, social-demographic data, measures of past treatment history, and prognostic indicators were of interest. Of interest regarding the therapist were general descriptive data about past experience treating , mos. 6, 12, 18, 24 Baseline, mos. 6, 12, 18, 24 Baseline, mos. 6, 12, 18, 24, termination Baseline, mos. 6, 12, 18, 24;  baseline mos. 6, 12, 18, 24, termination forward, a few words are in order about the project psychiatrists, psychological testers, and blind raters. The project psychiatrists were the investigators involved in planning the study and in weekly meetings to oversee the project. They were also involved in patient recruitment. The psychological testers were clinical psychologists with expertise in psychological testing. They were blind to the experimental conditions to which patients .were assigned and also unfamiliar with the study design and hypotheses. They were, as such, uninvested observers. The blind raters were experienced clinicianssocial workers, psychiatrists, and psychologists-who, like the psychological testers, were uninformed about the study, and uninvested in its outcome. All were trained extensively for reliability at the time they joined the project and were checked at intervals over the course of the project.
Data Management
To narrow down our vast array of variables and to generate more robust and reliable outcome measures for use in our main analyses, a series of clustering procedures was undertaken. As a first step, we conceptualized the five major domains of outcome relevant to this study. They included signs and symptoms, cognitive functioning, ego functioning, interpersonal relations, and role performance. We then clustered together, on a rational, a priori basis, 25 sets of variables that we believed would tap these domains. We chose variables only from those test instruments that were administered both at baseline and at followup.
Next we tested the adequacy of these conceptually derived dusters by calculating measures of internal consistency (Cronbach's alpha and item-whole correlations) for each proposed cluster. We examined the factor loadings of each item within each cluster on the first, unrotated principal component that was extracted when those items were factor analyzed. Although factor analyses are of questionable value when the number of variables is large relative to the number of subjects (as was the case in this study), we felt that these techniques might generate some meaningful groupings of variables that we had overlooked in our a priori conceptualization. Another aim of these analyses was to determine which of our tentatively proposed clusters needed to be modified and how best to modify them. We were guided by Nunnally's (1967) suggestion that a scale (in this case, a cluster) not be regarded as useful if more than half of its variance could consist of random error. Thus, efforts were made to improve upon all clusters with alpha coefficients below .50.
To do this, we first looked for items that clearly did not "fit" our hypothesized clusters. Based on an examination of natural breaks in the distributions of factor loadings, on item-whole correlations, and on changes in Cronbach's alpha when certain items were removed from the clusters, we were able to eliminate the most poorly fitting items and were left with a set of refined, though rather "thin," clusters. To see if these clusters could be made more substantial, we then looked for items that could be added to each. Instead of embarking on a fishing expedition through what still was a large array of variables, we conducted a conceptually guided empirical search. That is, we intercorrelated all of the items within a given domain, but not across domains, on the assumption that the most likely candidates for addition to a given cluster would be found in a conceptually related cluster within the same domain. This approach proved highly effective. We found a number of items that had been placed (conceptually) in one cluster, but that actually fit better in another. When these items were moved accordingly, a corresponding rise in the statistical coherence of the clusters was observed.
With the completion of these analyses, we had achieved two of our major goals. We had reduced our vast array of variables to a more manageable size and simultaneously had created a number of internally consistent groupings of variables. Having established that the items within the clusters comprising each outcome domain correlated reasonably well with each other, we then set out to determine if those items correlated better with each other than with items in the clusters comprising other outcome domains. This procedure was important because our clusters were not mutually exclusive. That is, some items still appeared in more than one cluster. The next stage of the clustering process was devoted to eliminating the remaining redundancy and simultaneously establishing the relative independence of our clusters. Using what now was a markedly reduced array of variables, we again factor analyzed our data, this time including items from all outcome domains and rotating combinations of factors until we arrived at the theoretically most meaningful and statistically most coherent and independent set of clusters. Table 12 contains a list of our final 15 clusters, along with the items comprising them, and their measures of internal consistency. The correlations among the clusters are contained in table 13.
To evaluate the information contained in these tables, it must be remembered that the approach we took in both stages of the clustering process, i.e., in both the "within" and "between" cluster analyses, was not purely empirical. For example, decisions made (in stage 1) to alter the composition of our clusters were based only in part on statistical considerations (alpha coefficients and .item-whole correlations). These decisions also were influenced by clinical and theoretical concerns. That is, the degree to which even "poor-fitting" items were judged to be clinically relevant also was taken into account when deciding on which items to retain and which to eliminate. Similarly, our selection of a final set of clusters (in stage 2) also was guided by our belief that some outcome dimensions were sufficiently important to retain as separate even if they were highly correlated with other dimensions. For example, one of the higher correlations in the cluster matrix shown in table 13 was .63 between global psychopathology and ego weakness, indicating substantial common variance. On purely statistical grounds, it would have been reasonable to combine these two clusters. However, on clinical, theoretical grounds, each of these was considered to be quite important so that, in spite of their relationship, these two clusters were kept separate rather than merged.
Having thus arrived at a set of clusters that we felt tapped all conceptually important domains of outcome and that were relatively coherent and independent, we next generated cluster scores for each patient at baseline. Since the clusters were composed of measures that had different scaling metrics, we had to transform the data to a common metric before we could calculate the cluster scores. This was done by computing z scores for all items, summing the z scores of the items within each cluster for each patient, and finally dividing the sum score by the number of valid observations obtained from the patient. This averaging procedure, instead of a simple summing procedure, was used to deal with missing data, something that was not a problem at baseline but was a problem at followup. . In this study, as in all longitudinal studies, there was progressive data attrition (see figure 1) . There was also a strong relationship between remaining in psychotherapy and providing followup data. Even though the majority of patients who were in therapy at the time of followup completed a full assessment battery, there were a number (10-20 percent) who were in therapy but completed only part of the followup or none at all. To be sure that the cluster scores assigned to patients adequately reflected their status at followup, we required that the patients have scores on at least twothirds of the variables comprising a given cluster in order to receive a valid score on that cluster. Otherwise, the case was considered to be missing those data and was deleted from analyses pertaining to ' that cluster at that time period.
With respect to the followup cluster scores, two other points should be made. First, cluster scores were not computed from the 18-month followup data. Due to limitations in manpower and funding, collection of these data was discontinued about halfway through the study, as we turned our attention to obtaining the more critical 2-year followup data.
The second point to be made is that the procedures used to generate cluster scores at followup were identical to those used at baseline, with one important modification. That is, all followup scores were computed on the basis of the baseline z distributions. We had two reasons for transforming the followup data relative to the baseline z distribution. One was that at baseline we had the largest sample and the best, most stable estimate of our clustered data. The second was that we wanted to be able to test for and interpret the main effects of time, which would not be possible if we obtained a new z distribution at each followup time period.
Once both baseline and followup cluster scores were computed for each patient, we performed one last set of analyses. We intercorrelated scores on the 15 clusters at each followup time period and also calculated test-retest correlations for each cluster. These analyses served as a final check on the adequacy of our clusters. We found that the pattern of intercorrelations among the clusters at each time period remained relatively unchanged (i.e., the clusters still were largely independent) and that the correlations between the baseline, 6-, 12-, and 24-month scores on each cluster were all moderately positive (i.e., the clusters were fairly stable over time). These are just the kinds of results that one would expect to find if our measures were responding in a reasonable way, and they gave us confidence in the dusters we had developed.
In addition to the 15 cluster measures described above, we also used 11 discrete measures to assess outcome in the areas of recidivism and role performance: number of days hospitalized, number of days on antipsychotics, number of days dependent, units of productive activity, number of days of fulltime employment, occupational level reached, number of rehospitalizations, number of job changes, degree self-supporting, level of household responsibilities assumed, and involvement in a significant relationship. These are measures that reflect functioning between baseline and subsequent periods-for example, between baseline and 6 months, baseline and 12 months-and that are thus cumulative over time.
Finally, a set of six more simple variables (unclustered) were selected because of their special interest to the project or for comparison with prior studies: Visual Verbal Test total misses, Camarillo Insight, and four scales from the Psychotherapy Outcome Interview, i.e., Longitudinal Awareness, Insightfulness, Object Relatedness, and Subjective Experience. More will be said about these measures in the subsequent report ).
Discussion
Staffing. Some staffing issues may be unique to the conduct of a long-term project involving a staff as large as that assembled for this project (see Appendix A). Some of these are related to the complexity of multiple sites. Others reflect problems inherent in long-term projects, including the discontinuities introduced by staff who move on to new positions, and problems in maintaining a competent and motivated assessment team given the extreme repetitiousness of tasks involved. Still other problems are unique to studies comparing two kinds of treatment in which the project investigators are known to be identified with one of the modalities-in this case, EIO. In the current study, this identification contributed to the suspiciousness with which the project was viewed by some RAS therapists.
A final staffing issue which deserves comment is that it proved far more practical to have raters who were paid on a contractual basis for their services than on a salaried basis. This reflects the irregularity with which patients enter the project and need their followup evaluations. When the flow is heavy, it is too much for one person; when it is slow, the salary is wasted. Moreover, in a collaborative, multihospital study within the same city, having a common pool of raters assures a uniformity of assessments that is not possible for salaried individuals who are institutionally based-even if, with the latter system, they get together periodically for reliability checks.
Overall Strengths and Weaknesses.
An overall strength of this project is the breadth and high quality of the data that was obtained on the subjects. Our assessments encompassed all of the major instruments used in previous studies and covered all the standard areas used to follow the course of schizophrenia, i.e., symptoms, role performance, and recidivism. Our data also extended into the areas usually considered to be less significant or given only peripheral attention. Thus, we paid special attention to the areas of psychological functioning in which insight-oriented psychotherapy might be expected to exert its more specific effects. Moreover, the baseline and followup assessments done on patients were accompanied by extensive assessments of the therapeutic process and of the therapists themselves. Our ongoing assessments of the patients' and therapists' views of process, supplemented by the extensive ratings made on tapes, present a unique and rich resource for study of psychotherapeutic processes over the course of longterm treatment. Moreover, the attention given to achieving reliability on the tape data in areas requiring sophisticated clinical infer-ences represents an advance in psychotherapy research methodology more generally. Similarly, the extensiveness and the highly personal nature of the assessments made on our therapists provide a basis for the study of the relationship of therapist characteristics to therapeutic process and outcome.
An important feature of this project's design and its implementation was the degree of blindness that was maintained. The following are some examples of our attention to this issue: We did not look at any outcome data until the project was completed to avoid the possibility that early results could influence later outcome. Noting that it was important to have at least some familiar staff people on hand to do aspects of the followups, any data gathered in this way were taped and subjected to independent rating by someone unfamiliar with the patient's or therapist's identity; all baseline assessments were completedincluding those unrelated to selection critera-before randomization was announced; though therapists were inadvertently aware of the comparative nature of the project, they were kept unapprised of specific hypotheses of expected changes lest such knowledge prejudice either their technique with patients or the patients' responses to their followup exams. This last precaution extended to members of the research team itself, who were precluded from participation in the project as therapists.
Another major strength of the psychotherapy outcome project was the high quality of treatment that the patients in both groups received. With respect to the qualifications of the therapists and the nature of the treatment that they delivered, the study's ambitious design was generally fulfilled. With respect to the experimental condition, the EIO therapy provided in this project is generally representative of intensive, insight-oriented treatment as commonly practiced with schizophrenic patients. Likewise the RAS therapy provided in this project is generally representative of high quality standard care administered presently to the majority of schizophrenic patients. Thus, the results of this study should have broad implications for understanding psychotherapy with schizophrenic patients.
It is noteworthy that the comparisons of our two therapy conditions on a number of background treatment variables showed them to be reasonably unconfounded by differential levels of other uncontrolled therapies, e.g., group, family, and couples therapy, day-evening and residential treatment, hospital milieu treatment, and antipsychotic medication usage. As noted in our literature review, differences in either pharmacotherapy or hospital setting enormously compromised the interpretation of several previous studies on psychotherapy of schizophrenia.
Another major area of strength characterizing this study was that a reasonably large sample of schizophrenic patients were maintained in their randomly assigned treatment over a 2-year period. Notwithstanding the serious problems of attrition, which have been noted, it represents a significant achievement to be able to maintain seriously disturbed patients in a controlled form of psychotherapy for both the inpatient and outpatient phases of treatment over the time period of this study. Previous studies of a 2-year duration relied upon the confinement and supports provided by long-term hospitalization.
A final area of strength in the project was the opportunity it provided for systematically exploring the issues of engagement and continuance in psychotherapy. This is clearly a significant issue in any long-term treatment strategy for schizophrenic patients-and perhaps for other treatments and clinical populations as well. As noted, studies have already been completed or are now underway to investigate characteristics in the patient, the therapists, and in the therapies themselves (including milieu and family) that are associated with subsequent sample attrition. It is, in any event, a major finding in itself that so many schizophrenic patients failed to continue in high quality therapy programs despite their financial feasibility.
Prominent among the study's weaknesses are the attrition problems that have been discussed, along with our failure to achieve the sample size that we had projected would be necessary to detect a treatment effect of moderate size. These issues of sample size and differential dropout are discussed in greater detail in the next article .
Another weakness in the study concerns the differences between hospitals on certain characteristics. On the one hand, the heterogeneity of the patient sample and the variability in the amount of hospital treatment received at the three participating institutions represents an advantage insofar as it broadens the population of patients and hospital stays to which our results may ultimately be generalized. Although the McLean, BU, and VA patients differed in a number of respects at baseline, within the hospitals there were no differences between the EIO and RAS samples. For other characteristics, such as the frequency of visits, the ratio of differences between EIO and RAS was the same from institution to institution. On the other hand, some hospital differ-ences were problematic-namely, differences between the EIO and RAS therapists that were called for by the design but appeared to be weak or absent. For example, at both the BU and VA sites, the EIO and RAS therapists differed less than we had hoped on our measures of past experience, treatment orientation, and treatment practices that were derived from therapy tapes and therapist reports. Although the EIO-RAS differences at these institutions were consistently in the direction called for by the design, the magnitude of differences was consistently less than at McLean and was less than that expected to be necessary to measure the differential effects of the two treatments. This issue also is discussed further in the next report .
A third problem was the failure of many therapists to tape record their therapy sessions in a consistent manner. Although the tape data collected are extensive, there was a noteworthy failure to get tape recordings from the RAS therapists. Although this problem limited our ability to make the comparisons between the RAS and EIO therapies as definitive as we had hoped, it was, to some extent, offset by the extensive process data on the content of sessions that was collected from patients and therapists in other ways.
Conclusion
This article gives an overview of the design, methods, and problems involved in attempting to do a controlled outcome study on the effects of psychotherapy with schizophrenic patients. It is to be hoped that the enormity of this task and the multiplicity of the contributors have come through. We believe that the areas in which we fulfilled the project's ambitious design can provide incentives and encouragement to psychotherapy researchers in the future and that the areas in which we failed to do so reflect the limitations of currently available methods and resources. It is our belief that much has been learned from this process which can help other investigators and that much will be learned from the ensuing reports which will help future patients. . This instrument was designed to discriminate the schizophrenic from nonschizophrenic patients. It was developed from the International Pilot Study of Schizophrenia (IPSS) and was one of three assessments used to screen patients for inclusion in this study. Based on information obtained in a clinical screening interview, the rater is asked to indicate whether the patient has each of the following 12 indicators of schizophrenia: absence of early awakening, thought broadcasting or thoughts heard aloud, nihilistic delusions, bizarre delusions, widespread delusions, absence of depressed facies, absence of elation, restricted affect, incoherent speech, poor insight, difficulties in rapport, and evidence of being an unreliable informant. To be considered for inclusion in the study, the patient had to fulfill five or more of these criteria (as well as have corroborating evidence for a diagnosis of schizophrenia). Interrater reliability (Kappa) for the 12 items ranged from .02 to .73 (median K -.42). (Vaillant 1964) . This measure was developed to identify schizophrenic patients with good prognosis and to separate process from reactive subtypes. On the basis of a clinical screening interview, the rater is asked to indicate whether each of seven symptoms are present or absent: acute onset of psychosis, confusion, nonschizoid premorbid adjustment, clear precipitating factors, affective features, concern with death, and a family history of depressive illness. The more of these that are present, the better the prognosis. Interrater reliability (Kappa) for the seven items ranged from .15 to .82 (median K -.70). (Phillips 1953) . This measure also is used to assess prognosis in schizophrenia and to differentiate between process and reactive subtypes. The patient is asked 12 open-ended questions about past and present social and sexual relationships and activities. The patient's responses are grouped into five areas of adjustment which are then rated on 5-or 6-point scales, where the higher the score, the poorer the adjustment. Interrater reliability (T index) for the five subscales ranged from .34 to .74 (median T -.47).
Psychopharmacology

Vailknt Prognostic Scale
Phillips Scale of Premorbid Adjustment
Demographic Information Questionnaire (project staff). This form was used to obtain basic social-demographic data on patients, to assess changes in their social and occupational functioning, to measure recidivism, and to monitor the type and amount of ancillary treatment received during the course of the study (e.g., group, couples, family therapy, rehabilitation services, and milieu treatment). Included on this form were questions about the patient's age, marital status, religious affiliation, educational level and experiences, occupational status and employment history, social class, living situation, financial and household responsibilities, involvement in social and recreational activities and relationships, type and amount of prior psychiatric treatment, history of drug and medication usage, and incidence and duration of any rehospitalizations that occurred during the study. Also included were questions about the patient's current and past caretakers, family constellation, and support networks, the incidence and type of mental illness in the patient's family, the type and amount of psychiatric treatment received by other family members, and the patient's perceptions of his/her family's support of the patient's current treatment program. Whenever possible, this information was obtained directly from the patient, via an interview. When this was not possible or when the patient was judged to be an unreliable informant, this information was obtained from other informed sources, e.g., family, previous treaters, and/or hospital records.
B. Therapist Measures
Therapist Background Questionnaire (project staff). This self-administered questionnaire was designed to screen therapists for inclusion in the study, to provide one means of characterizing the RAS and EIO therapist samples, and to permit an examination of therapist correlates of treatment outcome. From it, we obtained information about the therapists' training (e.g., psychoanalytic and other), general experience (e.g., years in practice), specific experience working with schizophrenic patients (e.g., number of cases treated, type and duration of treatments undertaken and completed), treatment preferences (e.g., for neurotic, psychotic, or personality disordered patients), and involvement in activities other than psychotherapy (e.g., research, teaching, hospital administration, consultation, liaison activities), as well as basic social-demographic data, including whether or not they had had personal analyses/therapy.
Therapy Opinion Questionnaire (Frosch, This self-administered questionnaire was designed to assess therapists' attitudes and beliefs about the nature, etiology, and treatment of schizophrenia. Therapists were asked to indicate, on 7-point scales, the degree to which they subscribed to each of 13 notions, comprising 3 categories: beliefs about the core problems in schizophrenia (that they are manifestations of deficits/defenses, are largely irreversible/reversible, and are primarily biological-hereditary/developmentalenvironmental in origin), (2) beliefs about effective treatment techniques (focus on the present/past, focus on the real/transference relationship, active structuring of therapy sessions, self-revelation, gratification of patients' wishes for advice, support, and direction), and (3) beliefs about the mechanism of change (the personality match between patient and therapist, medications, the milieu, a nonregressive therapy experience, and insight/corrective experience in a relationship). Interrater reliability (self vs. other, Pearson r) for the 13 scales ranged from .47 to .85 (median r = .72).
Therapist-Patient Personality Matching Scales (Gunderson, Schulz, and Feinsilver 1975) . These scales were used to identify "good" and "poor" therapist-patient matches and to test hypotheses about the effects on treatment processes and outcome of various types of therapist and patient personalities and personality«matches. There are two parallel forms of the instrument-one for the therapist, one for the patient. The therapist form is completed by senior clinicians who know the therapist well. Using 5-point scales, the clinicians rate the therapists on each of 10 personality dimensions deemed relevant to the treatment of schizophrenic patients: activity, comfort with aggression, tendency to externalize, manipulativeness, gentleness, grandfatherliness (comfort with sexual and other "id" material), comfort with depression, optimism, composure, and comfort with dependency. The patient form is completed by the therapists. Using the same 5-point scales, the therapists rate their patients on each of 10 corresponding dimensions: passivity, hostility, paranoia, sociopathy, fragility, seductiveness, depression, assigned hopelessness (poor prognosis), anxiety, and dependency. These ratings are then matched to yield 10 goodness-of-fit measures.
Therapist Pathogenesis Scale . This scale, developed from analyses of TAT protocols, has been shown to differentiate effective from noneffective psychotherapists of schizophrenic patients. It measures the degree to which therapists are inclined to use those dependent on them for their own interests or needs, regardless of whether they conflict with the dependent person's own interests and needs. Scores are based on blind ratings of self-administered TATs and may range from 0 to 100, where the higher the score, the more pathogenic the therapist. (Stone 1973, unpublished) . This instrument was used to assess the various types of interventions that were made by therapists. It asks therapists to indicate, on 4-point scales, the degree to which they engaged in each of 10 activities during the preceding month's therapy sessions: discussing drug management and side effects, discussing current behavior and symptoms, providing direct support, setting limits, manipulating the patient's environment, clarifying affective states and the relationships between events, interpreting unconscious motivations, working with transference and countertransference, exploring conflicts or the defensive nature of behavior, and exploring the patient's past, dreams, and fantasies.
II. PrOCeSS Measures Stone Report of Therapist Activities
Psychotherapy Status Report (project staff). This self-administered questionnaire was used to obtain therapists' ongoing evaluations of the psychotherapy process and their patients' use of the treatment, including their impressions of the current areas of focus in the treatment and the major areas of patient resistance. Using 5-point scales, therapists were asked to judge the stability of the treatment alliance, the degree to which the patient shared relevant material and expressly valued the therapy, showed an interest in understanding his/her illness, had a realistic view of the therapist, and was able to explore rather than act out conflicts, as well as to rate the degree to which they felt involved with the patient and optimistic regarding the treatment. In addition, therapists were asked to provide narrative summaries of the major topics addressed in the preceding month and to indicate, using a checklist, the degree to which the patient was adhering to the parameters of the treatment.
Monthly Therapy Record (project staff). This form was designed to assess the regularity of a patient's attendance at therapy sessions and to permit a determination of the degree to which the study protocol was being adhered to, in terms of frequency of sessions (1 session/week for RAS and 3 sessions/week for EIO patients). The format was such that therapists could readily tabulate the number of appointments scheduled and canceled in the preceding month, as well as the duration of the sessions that were held, and the frequency with which the patient arrived late and/or left early. Also recorded was information about the canceled appointments, i.e., whether the patient notified the therapist or simply failed to show up and whether the patient rescheduled the missed appointment.
Psychotherapy Process Rating Scales (Raskin 1961; Auerbach and Luborsky 1968; project staff) . These scales were used for the blind analysis of verbatim transcripts of two consecutive psychotherapy sessions drawn at random from each 6-month time period. They were designed for the purposes of characterizing the two forms of psychotherapy that were provided (RAS and EIO) and isolating those factors in either or both conditions that lead to change and that differentiate effective from noneffective therapists. Of the 37 five-point rating scales that we used, 24 pertained to the therapist's interventions (i.e., the degree to which the therapist gave suggestions or advice, educated the patient about therapy, supported a healthy reality orientation, gave encouragement and reassurance, softened/reinforced conscience, focused on the patient's ego functioning, interpersonal relationships, real and transference relationships with the therapist, used self-revelation and disclosure, explored unconscious affects and thoughts, focused on the past/present, was sensitive to undercurrents, was empathic, was responsive, was dynamically skilled, and was assertive, warm, and giving). The remaining 15 scales pertained to the patient's behavior in therapy (i.e., the patient's focus on crucial concerns, activity, anxiety, depression, hostility, guilt, concern regarding supplies, clarity of communications, psychotic manifestations, receptiveness, reflectiveness, insight, and overall responsiveness to and use of the therapy session). Most of the scales were descriptive, though some were evaluative. All were selected because of their presumed relevance to the process of psychotherapy in general and to schizophrenic patients in particular. Interrater reliabilities (intraclass r) ranged from .12 to .70 (median intraclass r -.47).
Barrett-Lennard Relationship Inventory (Barrett-Lennard 1962 , 1969a , 1969b . This self-administered questionnaire was designed to measure patients' perceptions of the therapeutic relationship. Patients are asked to indicate, on 6-point scales, the degree to which they agree (or disagree) with each of 64 statements describing their therapists. The items are grouped to form four scales, measuring the therapist's empathic understanding, congruence, level of positive regard, and unconditionality of regard.
Medications Inventory (project staff). This form enabled us to keep a daily record of each patient's medications, including type and amount prescribed and duration of usage. This information was obtained from hospital personnel or records for inpatients and from prescribing physicians for outpatients. Monthly totals and averages were computed for each of six groups of medications: antipsychotic, antianxiety, sedative, antidepressant, antiparkinsonian, and lithium. All medication dosages, within each group, were converted into equivalent units (e.g., all antipsychotics were transformed into Thorazine units, all antidepressants into Elavil units.).
Daily Activities Chart (DAC) (project staff). This form was designed to ascertain the type and quantity of vocational, recreational, and treatmentrelated activities entered into by the patient while in the hospital. The patient is asked 12 questions about his/her level of participation in ward-sponsored, hospital-sponsored, and self-initiated activities; in informal interactions with family, friends, and other patients; and in more formal interactions with staff around treatment plans, during the preceding week. The number of times that the patient engaged in each is recorded.
Nursing Notes (project staff). These measures were designed to provide an unobtrusive assessment of the hospital staff's interest in and involvement with the patient. They were derived from entries made in the patient's chart, primarily by nursing staff and mental health workers, as part of regular hospital procedures. At nine randomly chosen times during the patient's first 6 months of hospitalization, the patient's chart was reviewed and a series of ratings made. Among the information recorded was the number of times a patient's case was reviewed in rounds during the preceding week, the number of staff members who made chart entries on the patient, and the total number and length of the entries made. These were averaged to yield five measures of staff interest and involvement for the entire time period.
Nurses Observation Scale for Inpatient Evaluation (NOSIE-30) (Honigfeld and Klett 1965; Honigfeld, Roderic, and Klett 1966) . This instrument was designed to provide an unobtrusive assessment of changes in the overt behavior of hospitalized psychiatric patients. The staff member who is most familiar with the patient's everyday behavior on the ward rates, on 5-point scales, the degree to which the patient showed evidence of each of 30 pathological behaviors in the preceding week. The 30-item ratings are grouped to form 6 subscale ratings (of retardation, social incompetence/competence, social lack of interest/interest, personal sloppiness/neatness, irritability, and manifest psychosis) as well as a single macro-scale rating (of total patient liabilities/assets).
Ward Atmosphere Scale (Moos 1974) . This self-administered inventory is used to assess patient and staff perceptions of the social environment of hospitalbased psychiatric treatment programs. It consists of 100 true-false items that form 10 subscales, measuring relationship aspects of the milieu (patient and staff involvement, support, and spontaneity), the treatment orientation of the milieu (toward autonomy, practical goals, personal problems, and open expression of anger), and system maintenance features of the milieu (order and organization, program clarity, and staff control). Although it was designed to measure differences between patients and staff in their views of an inpatient milieu, it was used in this study to identify differences between various hospital milieus.
III. Outcome Measures
Psychiatric Status Schedule (PSS) (Spitzer et al. 1970) . This is an instrument that contains both a standardized interview schedule and a matching inventory of 321 true-false items descriptive of small units of psychopathology. The assessment focuses on recent social functioning and symptomatology. Both the patient's responses to the interview questions and observable behavior during the interview are scored. These scores are grouped to yield 17 symptom measures (depression-anxiety, daily routine-leisure time impairment, social isolation, suicide/self-mutilation, somatic concerns, speech disorganization, inappropriate affect, appearance and behavior, agitation-excitement, interview belligerence-negativism, disorientation-memory, retardation-lack of emotion, antisocial impulses or acts, drug abuse, alcohol abuse, reported overt anger, grandiosity, and suspicion-persecution-hallucinations) and six role measures (denial of illness, wage earner role, housekeeper role, student or trainee role, mate role, and parent role). These in turn are grouped to yield four macrosymptom scales (subjective distress, behavioral disturbances, impulse control disturbances, and reality-testing disturbances) and one macro-role performance scale. In all cases, the higher the scale score, the more psychopathology.
Computer-generated diagnoses also can be obtained using a subset of the instrument's items. Interrater reliabilities (intradass r) ranged from .21 to .99 (median intraclass r ™ .91). (Lorr, Klett, and McNair 1963) . This 75-item instrument was designed to provide a quantitative assessment of the behaviors, affects, and symptoms commonly shown by hospitalized psychotic patients. It is completed after a standard clinical interview, which in this study was the PSS interview. Most of the items are scored using 5-or 9-point rating scales; some items are scored simply as present or absent. For all items, raters are advised to score only that which is directly observable or readily inferable. When grouped, the scores form 10 subscales (excitement, hostile belligerence, paranoid projection, grandiose expansiveness, perceptual distortion, anxious-intropunitiveness, retardation-apathy, disorientation, motor disturbances, and conceptual disorganization) and three macroscales (excitement/retardation, distortion of thinking and perception, and schizophrenic disorganization). For all scales, the higher the score, the more psychopathology. Interrater reliabilities (intraclass r ) ranged from .16 to .99 (median intraclass r = .51).
Inpatient Multidimensional Psychiatric Scale (IMPS)
Menninger Health-Sickness Rating Scale (Luborsky 1975) . This instrument provides a global evaluation of a patient's functioning on a scale ranging from 1 to 100, where the higher the score, the less functional the patient. While only a single overall rating is obtained, raters are advised to consider various aspects of patient functioning (e.g., ability to function autonomously, seriousness of symptoms, subjective distress, degree to which the patient can use abilities, and quality of interpersonal relationships) when making their evaluation, and are given sample descriptions of patients receiving various scores on the scale. Any standard clinical interview can serve as the basis for rating patients. In the present study, the PSS was used for this purpose. Interrater reliability for this scale was .92.
CamariUo Dynamic Assessment Scale (May and Dixon 1969) . This instrument is designed to provide a psychodynamic assessment of patients and to tap important aspects of schizophrenic functioning. Based on a clinical interview, ratings of patient performance in eight areas (affective contact, ego strength, anxiety level, object relations, impact on the environment, sense of personal identity, insight, and motivation) are made on 7-, 9-, or 11-point scales, where the higher the score, the worse the performance. Interrater reliability (Pearson r) for the eight subscales ranged from .30 to .91 (median r = .88).
Wechsler Adult Intelligence Scale (WAIS) (Wechsler 1955) . This standard psychological test is used to provide both general and specific measures of intel-lectual performance and cognitive organization. These measures are derived from two scoring methods. The first, and standard, method yields 11 subtest scores that tap such functions as judgment, concrete/abstract thinking, attention and concentration, fund of knowledge, capacity to synthesize and integrate new information, and three IQ scores (verbal, performance, and fullscale). The second method (Rapaport, Gill, and Schafer 1968) yields 12 "scatter" scores that tap disruptions in cognitive functioning, especially those thought to be specific to schizophrenia.
Rorschach. This standard projective test is used to provide measures of both cognitive and ego functioning. The test was administered in traditional fashion (Klopfer 1954) with one modification. That is, for each percept, the additional inquiry, "How does this make you feel?" was made. Scoring (of verbatim transcripts of test protocols) was done blindly using the Holt (Holt and Havel I960; Holt 1968 ) Primary Process Scoring System. This system yields measures of defensive operations, e.g., capacities for adaptive regression and creativity, as well as measures of the form and content of thought, and the type and level of primary process intrusions. Interrater reliability (Pearson r) for the 13 measures ranged from .61 to .98 (median r = .93).
Thematic Apperception Test (TAT). This standard projective test is used to measure a variety of personality characteristics and cognitive and ego functions. The test was administered in the standard manner prescribed by Murray (1943) . Verbatim transcripts of the test protocols then were blindly rated using the Barrington (1967) scoring system, a system that was developed for use in the study of psychotherapy with schizophrenic patients. This system provides measures of a patient's openness to/defensive avoidance of emotional experiences, sensitivity to and use of emotional reactions to guide behavior, dependency/autonomy strivings, interest in and expectations of satisfaction from relationships, self-confidence, and intellectual productivity. Interrater reliability (intraclass r) for the 13 measures used in the study ranged from .61 to .99 (median intraclass r -.93).
Visual-Verbal Test (VVT) (Feldman and Drasgow 1951) . This test is a modified version of a concept formation test used to discriminate schizophrenic patients from patients with organic brain syndromes. It measures conceptual thought deficits, i.e., difficulties in forming categorical concepts and in changing to new concepts once a particular one has been formed, and is administered in conjunction with a standard battery of psychological tests. The patient is asked to look at 42 groupings of four items and to state two points of commonality (two concepts) exhibited by three of the four items displayed. The number of errors made in forming concepts and shifting to new concepts is recorded.
Psychotherapy Outcome Interview (POI) (Gunderson and Gomes-Schwartz 1980) . This semistructured interview was developed to identify changes in a schizophrenic patient's psychological functioning that the clinical literature and experienced therapists had suggested should occur as a result of a successful psychotherapy. Patients are asked a series of specific questions designed to measure their capacities in nine areas: recognition of the continuity between past and present, object love and differentiation, object need and trust, ability to accept rather than externalize or project internal conflicts, self-observation, recognition of and efforts to control or master stressful situations, tolerance for uncertainty and helplessness, realistic recognition of personal limitations, and affective flexibility. The interview is tape recorded and the patients' responses in each area are blindly scored on 7-point scales to indicate the degree to which each capacity is present. Interrater reliability (T index) for the nine scales ranged from .39 to 1.00 (median T = .59). (Katz and Lyerly 1963) . These scales were developed to measure symptoms, social behaviors, and attitudes associated with adjustment, both in the hospital and in the community. There are two parallel versions of the instrument. One, the KAS-S, is completed by the subject/patient. The other, the KAS-R, is completed by a "significant other," usually a relative who has had the recent experience of observing and interacting with the patient. Both call for ratings on 4-point scales, and both include descriptive and evaluative assessments of the patient's social and recreational functioning. The KAS-R, in addition, includes items designed to enable the significant other to characterize the way in which the patient interacts with others, in terms of the following: belligerence, verbal expansiveness, negativism, helplessness, suspiciousness, anxiety, withdrawal, nervousness, confusion, bizarreness, hyperactivity, nonstability, general psychopathology, social obstreperousness, acute psychoticism, and withdrawn depression. (Soskis and Bowers 1969) . This self-administered questionnaire was designed to tap schizophrenic patients' attitudes toward their experience of psychosis, recent and remote. Patients are asked to read a series of 55 statements and check whether each does or does not apply to themselves. The items are grouped into 11 clusters of five statements each. Six of the clusters measure opposite (positive and negative) attitudes that the patient holds about his/her illness, the future, and the value of insight; three of the clusters measure beliefs about the source of major responsibility for the psychosis (self, family, or external events); two of the clusters tap whether the patient tends to integrate or isolate the psychotic experience.
Katz Adjustment Scales (KAS-S and KAS-R)
Soskis Attitude Toward Illness Questionnaire
Gottschalk Social Alienation/Personal Disorganization Scale (Gottschalk and Gleser 1964) . This measure, said to reflect global schizophrenic symptomatology (Gottschalk et al. 1970) , is derived from the content analysis of a 5-minute, tape-recorded speech sample of an interesting or dramatic life experience provided by the patient. The speech sample is transcribed verbatim and is blindly rated using the Gottschalk-Gleser method. A score ranging from 0 to 48 is obtained, where the higher the score, the greater the schizophrenic pathology. Interrater reliability (Pearson r) for this scale was .92.
